
Venture capital · Early stage · Est. 2016
AdBio
AdBio Partners is a Paris-based venture capital firm focused on early-stage life sciences and biotech startups in Europe, often built from academic research, with offices in Paris, Barcelona and Montréal.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is AdBio right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (ESMA register).
Latest investments
Rounds AdBio joined, from press and the firm’s own posts.
Every round AdBio joined
Round sizes, AdBio’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company AdBio backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet AdBio
Events where AdBio’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
AdBio is based in Paris, France. It also has offices in Barcelona and Montréal. Its registered address is 4 rue Thenard 75005 Paris France.
In 2016.
3 fund vehicles are on public registers (ESMA register), including ADBIO FUND III, AFB FUND II and AFB SEED-FUND I.
Stages: Early stage. Sectors: Life sciences. From the firm’s own website.
Backs early-stage life sciences startups, building companies from academic innovations in partnership with technology transfer offices and scientific founders. Acts as both investor and entrepreneur: scouts science, co-founds, provides initial funding, builds management teams (even interim CEO), and supports development plans, R&D strategy and growth. From the firm’s own website.
AdBio lists 26 portfolio companies on its website, including Alderaan Biotechnology, AndzonBio1, AndzonBio2, Agomab Therapeutics and AndzonBio.
Firms whose websites list some of the same companies include Asabys Partners, Columbus Venture Partners and Invivo Partners.
Know before AdBio’s next round is announced.
PRO tracks AdBio’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.